Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial

BACKGROUND: Patients with heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) represent a high-risk phenotype. The Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (RELAX) trial enrol...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Card Fail
Huvudupphovsmän: Patel, Ravi B., Mehta, Rupal, Redfield, Margaret M., Borlaug, Barry A., Hernandez, Adrian F., Shah, Sanjiv J., Dubin, Ruth F.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078015/
https://ncbi.nlm.nih.gov/pubmed/31931098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2020.01.003
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk